Related references
Note: Only part of the references are listed.The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
Alejandro Vazquez-Martin et al.
CELL CYCLE (2009)
Insulin Receptor Expression by Human Prostate Cancers
Michael E. Cox et al.
PROSTATE (2009)
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
Valter Donadon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
The growing burden of diabetes mellitus in the US elderly population
Frank A. Sloan et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Insulin, insulin-like growth factors and neoplasia
Michael Pollak
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004
Cristina Bosetti et al.
HEPATOLOGY (2008)
The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes - Results from Metascreen, a multicenter diabetes clinic-based survey
Riccarcdo C. Bonadonna et al.
DIABETES CARE (2006)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
HB El-Serag et al.
GASTROENTEROLOGY (2004)
Hyperinsulinemia predicts fetal liver cancer but is inversely associated with fatal cancer at some other sites -: The Paris Prospective Study
B Balkau et al.
DIABETES CARE (2001)
Share Paper
